|
|
 |
|
Viewing report
|
|
|
|
Pharmaceutical CME: Measuring Program Effectiveness in the Compliance Environment
Cutting Edge Information, Sep 2006, Pages: 165
Pharmaceutical CME departments struggle to measure performance for a number of reasons. The lack of hard measures for medical education, along with a fear of appearing non-compliant stops many companies from tracking return on investment (ROI). Many medical education departments use post-CME outcomes measures to judge the effectiveness of their investments in CME events. Unfortunately, attendance figures are the only hard measurement available from outcomes measurements – and high attendance numbers do not always translate into effective programs.
This study presents best practices and strategies for measuring CME program effectiveness, as well as explores the recent changes that pharmaceutical CME teams have undergone since the Office of Inspector General (OIG) published its guidance document in 2003. The study is a comprehensive look at the pharmaceutical industry’s strategies and support for CME in the current compliance environment.
Pharmaceutical CME: Measuring Program Effectiveness in the Compliance Environment explores the current challenges facing continuing medical education, as well as includes trend analysis, successful strategies and best practices. The study’s major focus areas include:
CME Structure, Staffing and Spending – The report collects case studies and benchmark data to underscore CME investment trends and reorganization strategies to remain compliant with industry regulations.
CME Program Strategies and Goals – Analysts compared industry-leading strategies and outlined goals for CME departments.
Grants Process – The study identifies best practices in standardizing the CME grants request process. The study also outlines changes in the process to meet with new compliance standards.
Evaluating Program Management and Effectiveness – The most effective CME departments in the pharmaceutical industry invest in various vehicles to deliver medical education to target physician audiences. The report compiles best practices and industry trends regarding the ideal CME media mix, including live events, eCME and enduring content.
Performance Measurement – Our analysts took a strategic look at hard and soft measures that pharma companies use to determine return on investment and return on education.
CME Compliance – The study outlines top compliance challenges and presents solutions for pharmaceutical companies to operate effective CME programs in an ever-changing compliance environment.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Best Practices in Recruitment for Medical Education Programs
Educating the Market: Creating Value Through Support of Continuing Medical Education
Cme Group Incorporation
CME Group Berhad
Online CME: a tool for the pharmaceutical marketer
US number of continuing medical education ( CME ) providers by 15 organizational categories, with CME income, expenses and surplus in dollars by organization type for 1999
Pharmaceutical Speaker Programs: Measuring ROI and Communicating Value
US continuing medical education ( CME ) expenses, income and profit margin in dollars for 1999 by provider class ( academic organizations vs "others" ), with number of accredited CME providers
Sales Force Effectiveness
eHealth Solutions for Pharma: Strategies for Salesforces, Marketing, Patient Compliance and Clinical Trials
Online Continuing Medical Education: Trends in the US and European eCME Markets
Barclays Capital Global Financial Services Conference - CME Group, Inc., - Earnings Transcript
|
|
|
|
